Results 131 to 140 of about 55,948 (258)

Indications for Surgery in Obstructive Hypertrophic Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Mark V. Sherrid
doaj   +1 more source

Pancreatic cancer cachexia promotes cardiac dysfunction through altered adrenergic signalling in the heart

The Journal of Physiology, EarlyView.
Abstract figure legend The β1‐adrenergic receptor is the predominant adrenergic subtype expressed on cardiac myocytes. Upon stimulation it activates downstream signalling pathways that increase the heart rate and cardiac output to meet metabolic demands.
Parham Diba, Peter R. Levasseur, Samuel D. Newton, Khia Min Sabrina Koh, Paige C. Arneson‐Wissink, Xinxia Zhu, Peter Pham, Heike Mendez, Luke Whitcomb, Ariana Sattler, William R Woodward, Beth A. Habecker, Daniel L. Marks, Aaron J. Grossberg   +13 more
wiley   +1 more source

[Hypertrophic cardiomyopathy. Arrhythmia in hypertrophic cardiomyopathy].

Archivos de cardiologia de Mexico, 2003
Hypertrophic cardiomyopathy is a relatively common genetic disorder with heterogeneity in mutations, forms of presentation, prognosis and treatment strategies. Hypertrophic cardiomyopathy is recognized as the most common cause of sudden cardiac death that occurs in young people, including athletes.
openaire   +1 more source

Beat‐to‐beat variability of ventricular repolarization reveals sex‐specific instability and proarrhythmic risk

The Journal of Physiology, EarlyView.
Abstract figure legend A mechanistic framework linking sex‐dependent dynamical instability to proarrhythmic risk. Sex‐specific human ventricular models show that upstream modulators, including biological sex, hormones, drugs and heart disease, promote steeper APD restitution in female than male and enhance dynamical instability.
Daisuke Sato, Lorenzo Santini, Raffaele Coppini, Eleonora Grandi   +3 more
wiley   +1 more source

Takotsubo Syndrome Mimicking Apical Hypertrophic Cardiomyopathy: A Case Report. [PDF]

Clin Case Rep
Vögeli B, Hacialioglu RA, Cevik B, Flury J, Payus AO, Arenja N.   +5 more
europepmc   +1 more source

Correction: Multimodality imaging in hypertrophic cardiomyopathy. [PDF]

J Cardiovasc Imaging
Kim J, Lee SC.
europepmc   +1 more source

Optimized Reduced Field of View and Fat Suppression Methods for Interleaved Multislice In Vivo Cardiac Diffusion Tensor Imaging

Magnetic Resonance in Medicine, Volume 96, Issue 3, Page 1097-1110, September 2026.
ABSTRACT Purpose Slice interleaving, a limited phase encode (PE) field of view (FOV), and effective fat suppression are vital for efficient cardiac diffusion tensor imaging (cDTI) with minimal artifacts. This study aimed to optimize reduced FOV and fat suppression methods for interleaved multislice cDTI to improve signal‐to‐noise ratio (SNR) and ...
Yaqing Luo, Pedro F. Ferreira, Ke Wen, Ricardo Wage, Guang Yang, Dudley J. Pennell, Sonia Nielles‐Vallespin, Andrew D. Scott   +7 more
wiley   +1 more source

Uncertainty Quantification for Cardiac Diffusion Tensor Imaging Without Additional Datasets

Magnetic Resonance in Medicine, Volume 96, Issue 3, Page 1458-1463, September 2026.
ABSTRACT Purpose Cardiac diffusion tensor imaging (cDTI) is subject to physiological noise, thermal noise, and signal corruption, which cause errors in diffusion measures. While a larger dataset can be decimated to investigate the general precision of measures from fitting smaller datasets, uncertainty quantification (UQ) methods for fitting entire ...
Sam Coveney, Irvin Teh, May Lwin, Mehak Asad, Isaac Watson, Maryam Afzali, Erica Dall'Armellina, Jürgen E. Schneider   +7 more
wiley   +1 more source

Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition. [PDF]

Eur Heart J Open
Govind A.
europepmc   +1 more source

The 9th International RASopathies Symposium

American Journal of Medical Genetics Part A, Volume 200, Issue 8, Page 1934-1941, August 2026.
ABSTRACT The RASopathies are a group of congenital disorders with overlapping clinical manifestations that are caused by pathogenic germline or early somatic variants that result in the hyperactivation of the RAS/mitogen‐activated protein kinase (MAPK) signaling pathway.
Pau Castel, Lisa Schoyer, Beth Stronach, Raya Bogdanova, Anton M. Bennett, Jaishri Blakeley, Miriam Bornhorst, Tammy Bowers, Saskia M. Brachmann, Emma Burkitt‐Wright, Kathryn Chatfield, Alessandro De Luca, Khalil El‐Chammas, Abdul Elkadri, John E. Fortunato, Bruce D. Gelb, Anne Goriely, Karen Gripp, Kassidy Grover, Lindsay Homan, Kenneth A. Kern, Maija Kiuru, Charles (Chuck) Lawson, Yong‐Seok Lee, Frank McCormick, Gina Ney, Cristina Nuevo‐Tapioles, Sara Pardej, Elizabeth I. Pierpont, Julia Plank, Nancy Ratner, Katherine A. Rauen, J. Elliott Robinson, Les Rogers, Sarah E. Sheppard, Keir Shiels, David Stevenson, Dagmar Tiemens, Matthew Traylor, K. Nicole Weaver, Marielle Yohe, Tamar Green   +41 more
wiley   +1 more source